Pharma stocks

Market update: Sensex down by 400 points, Nifty below 14,800

Sensex opened 0.81 percent, or 405.05 points, lower at 49,360.89, while the Nifty50 index opened at 14,747.35, down 147.55 points, or 0.99 percent. Midcap and smallcap indices saw a decline of over half a percent each. Among sectoral indices, banks, metals, financial services, and auto suffered loss, while gains were seen in Nifty IT and Nifty Pharma.

Apr 30, 2021, 09:43 AM IST

Nifty gains for 5th staright day on bouts of value buying

Selling in pharma, metal and private bank stocks capped the gains as investors turned cautious on expectations of likely continuity in Fed rate hike and rising oil prices.

Nov 22, 2017, 18:50 PM IST

Pharma stocks may outperform in the market

Pharma stocks may outperform in the market. Watch this special segment and get to know more here.

Apr 19, 2017, 18:03 PM IST

Expert Analysis on Pharma Sector

Share Bazar, Mandi Live, Aap Ka Bazar, First Trade, Big Debate etc.

Apr 04, 2016, 13:10 PM IST

Sensex ends at 2-week low as pharma stocks bleed, Nifty slips below 7,600-mark

Pharma stocks took a heavy beating after some companies from the sector received observations from the US health regulator.

 

Mar 29, 2016, 17:24 PM IST

Budget 2016-17: Stocks on radar

Check out how Budget announcements are likely to impact some key stocks.

 

 

Feb 11, 2016, 17:01 PM IST

Sensex ends 5-day losing streak, rebounds by 214 points

Sensex Wednesday rebounded by over 214 points to 27,890.13 on value-buying in capital goods, pharma and banking stocks as sentiment improved after Saudi Arabia ended its military campaign in Yemen.

Apr 22, 2015, 17:31 PM IST

Sensex rises to near 2-week high; pharma stocks surge

The Nifty gained 0.45 percent, while the benchmark BSE Sensex rose 0.5 percent, marking their highest level since March 24.

Apr 06, 2015, 15:06 PM IST

Nifty ends with marginal gains, up 4 points

The NSE benchmark Nifty today washed out most of its initial gains and closed just 3.85 points up after markets witnessed fag-end selling pressure in key banking, energy and pharma counters.

Feb 16, 2015, 21:41 PM IST